Drug Database
Back to search

Germany· DE-A57-1be03a22becc3efe

Alfason Crinale

A hydrocortisone butyrate product containing hydrocortisone butyrate, registered in Germany by Cheplapharm Arzneimittel Gmbh. The same ATC class is registered in 13 of our 19 countries.

ATC D07AB02

Checked against EMA Article 57 (European Union) on

Informational only — not a medical device.

SOURCE REGISTER · DEEMA Article 57 (European Union)normalisedAlfason CrinaleATCD07AB02REGISTER NO.DE-A57-1be03a22becc3e…PACKS LISTED0CHECKEDSeptember 30, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about hydrocortisone butyrateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Hydrocortisone butyrate is registered in 13 of 19 countries.

Countries holding a registration under ATC D07AB02 (hydrocortisone butyrate), each read from that country’s own register.

  • This record: Germany, from EMA Article 57 (European Union)
  • 8 of them publish a price we can compare per daily dose
Search hydrocortisone butyrate products by name

Hydrocortisone butyrate · ATC D07AB02

13 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

EMA Article 57 (European Union)
Active substance
Hydrocortisone Butyrate
Manufacturer
Cheplapharm Arzneimittel Gmbh
Country
Germany (DE)
ATC code
D07AB02
ATC class
Hydrocortisone butyrate
Reimbursed
Not published by this register
Source register
EMA Article 57 (European Union)
Last checked
September 30, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

55 interactions on record for hydrocortisone butyrate.

Graded by severity as the source publishes them — 55 minor. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check hydrocortisone butyrate against other medicinesHow interaction checks work

Hydrocortisone butyrate · interactions on record

55 records

  • 55 minor

Most severe, free to view

    Mechanism and what to do, in the interaction check
    Interaction register. Grades as the source publishes them.

    Same medicine, other countries

    Hydrocortisone butyrate in 8 other countries

    What each register calls a product with the same active substance — salts and hydrates count as the same.

    All hydrocortisone butyrate products

    Authorised across Europe · EMA

    The same active substance is authorised in 22 EEA countries. Names it is sold under:

    • Belgium · Locoid, Locoid Crelo
    • Bulgaria · Локоид Липокрем
    • Czechia · Locoid, Locoid Crelo
    • Denmark · Locoid, Locoid Crelo
    • Finland · Bucort, Locoid
    • France · Locoid
    • United Kingdom (Northern Ireland) · Locoid, Locoid Crelo
    • Hungary · Laticort, Locoid
    • Ireland · Locoid, Locoid Lipocream
    • Iceland · Locoid, Locoid Crelo
    • Italy · Locoidon
    • Lithuania · Laticort
    • Luxembourg · Locoid, Locoid Crelo
    • Latvia · Laticort
    • Malta · Locoid, Locoid Lipocream
    • Netherlands · Locoid Crelo, Locoid Crème
    • Norway · Locoid, Locoid Crelo
    • Poland · Laticort, Locoid
    • Portugal · Locoid, Locoid Capilar
    • Romania · Locoid, Locoid Lipocream
    • Sweden · Locoid, Locoid Crelo
    • Slovakia · Locoid, Locoid Crelo

    Source: European Medicines Agency, Article 57 product data.

    Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

    For developers

    The same record over the API, and the raw payload
    GET /v1/drugs/6c397c4f-8143-4c9e-8f78-9516186f7eea
GET /v1/drugs/6c397c4f-8143-4c9e-8f78-9516186f7eea?format=fhir

    Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

    {
  "pzn": null,
  "route": "Cutaneous Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Hydrocortisone Butyrate",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}
    API referenceMCP serverPlans

    See everything about hydrocortisone butyrate.

    This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

    Try it freeOpen in the console